[HTML][HTML] Nanotechnology-based strategies against SARS-CoV-2 variants

X Huang, E Kon, X Han, X Zhang, N Kong… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already infected more
than 500 million people globally (as of May 2022), creating the coronavirus disease 2019 …

[HTML][HTML] Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic

AM South, L Tomlinson, D Edmonston… - Nature Reviews …, 2020 - nature.com
The current COVID-19 pandemic is associated with unprecedented morbidity and mortality.
Early reports suggested an association between disease severity and hypertension but did …

[HTML][HTML] COVID-19 and hypertension: the what, the why, and the how

SA Muhamad, A Ugusman, J Kumar, D Skiba… - Frontiers in …, 2021 - frontiersin.org
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …

Diabetes and COVID-19: Global and regional perspectives

IK Jeong, KH Yoon, MK Lee - Diabetes Research and Clinical Practice, 2020 - Elsevier
Abstract The coronavirus disease-2019 (COVID-19) has been designated as a highly
contagious infectious disease caused by the severe acute respiratory syndrome coronavirus …

[HTML][HTML] A historical perspective on ACE2 in the COVID-19 era

V Bhalla, CA Blish, AM South - Journal of Human Hypertension, 2021 - nature.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Lessons learned from severe acute respiratory syndrome …

Pediatric primary hypertension: an underrecognized condition: a scientific statement from the American Heart Association

B Falkner, SS Gidding, CM Baker-Smith, TM Brady… - …, 2023 - Am Heart Assoc
The overall prevalence of hypertension in childhood is 2% to 5%, and the leading type of
childhood hypertension is primary hypertension, especially in adolescence. As in adults, the …

Renin-angiotensin system and sex differences in COVID-19: a critical assessment

MC Chappell - Circulation Research, 2023 - Am Heart Assoc
The current epidemic of corona virus disease (COVID-19) has resulted in an immense
health burden that became the third leading cause of death and potentially contributed to a …

ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic: the pediatric perspective

AM South, TM Brady, JT Flynn - Hypertension, 2020 - Am Heart Assoc
Potential but unconfirmed risk factors for coronavirus disease 2019 (COVID-19) in adults
and children may include hypertension, cardiovascular disease, and chronic kidney …

Severe acute respiratory syndrome coronavirus 2, COVID-19, and the renin-angiotensin system: pressing needs and best research practices

MA Sparks, AM South, AD Badley, CM Baker-Smith… - …, 2020 - Am Heart Assoc
The coronavirus disease 2019 (COVID-19) pandemic is associated with significant morbidity
and mortality throughout the world, predominantly due to lung and cardiovascular injury. The …

[HTML][HTML] ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection

S Abdelsattar, ZA Kasemy, SF Ewida… - British Journal of …, 2022 - frontierspartnerships.org
Background: Genetic risk factors may be related to the infectivity and severity of SARS-CoV-
2 infection. Angiotensin-converting enzyme 2 (ACE2) and host transmembrane serine …